Literature DB >> 24906799

The ubiquitin-conjugating enzymes UBE2N, UBE2L3 and UBE2D2/3 are essential for Parkin-dependent mitophagy.

Sven Geisler1, Stefanie Vollmer2, Sonia Golombek2, Philipp J Kahle3.   

Abstract

Depolarized mitochondria are degraded by mitophagy in a process that depends on the Parkinson's disease gene products PINK1 and Parkin. This is accompanied by ubiquitylation of several mitochondrial substrates. The roles of E2 ubiquitin-conjugating enzymes (UBE2) in mitophagy are poorly understood. Here, we investigate a set of UBE2 enzymes that might regulate Parkin-mediated mitophagy. Knockdown of the E2 enzymes UBE2N, UBE2L3 or UBE2D2 and UBE2D3 (UBE2D2/3) significantly reduced autophagic clearance of depolarized mitochondria. However, this did not interfere with mitochondrial PINK1 stabilization and Parkin translocation. UBE2N knockdown prevented specifically K63-linked ubiquitylation at mitochondrial sites. Nevertheless, polyubiquitin and p62 (officially known as SQSTM1) were still found on mitochondria after individual UBE2 knockdown. Knockdown of all of these UBE2s together significantly reduced mitochondrial polyubiquitylation and p62 recruitment. Moreover, reduced ubiquitylation of mitofusins, the mitochondrial import receptor subunits TOM20 and TOM70, the voltage-dependent anion channel protein 1 and Parkin was observed in cells silenced for all of these UBE2s. A version of Parkin with a mutation in the active site (C431S) failed to ubiquitylate these mitochondrial substrates even in the presence of UBE2s. We conclude that UBE2N, UBE2L3 and UBE2D2/3 synergistically contribute to Parkin-mediated mitophagy.
© 2014. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Mitophagy; Parkin; Proteasome; UBE2; Ubiquitin

Mesh:

Substances:

Year:  2014        PMID: 24906799     DOI: 10.1242/jcs.146035

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  48 in total

1.  How phosphoubiquitin activates Parkin.

Authors:  Xinde Zheng; Tony Hunter
Journal:  Cell Res       Date:  2015-08-11       Impact factor: 25.617

Review 2.  Activation of the E3 ubiquitin ligase Parkin.

Authors:  Thomas R Caulfield; Fabienne C Fiesel; Wolfdieter Springer
Journal:  Biochem Soc Trans       Date:  2015-04       Impact factor: 5.407

3.  Phospho-ubiquitin-PARK2 complex as a marker for mitophagy defects.

Authors:  Sylvie Callegari; Silke Oeljeklaus; Bettina Warscheid; Sven Dennerlein; Michael Thumm; Peter Rehling; Jan Dudek
Journal:  Autophagy       Date:  2016-11-15       Impact factor: 16.016

Review 4.  Autophagosome dynamics in neurodegeneration at a glance.

Authors:  Yvette C Wong; Erika L F Holzbaur
Journal:  J Cell Sci       Date:  2015-04-01       Impact factor: 5.285

5.  Aged monkey brains reveal the role of ubiquitin-conjugating enzyme UBE2N in the synaptosomal accumulation of mutant huntingtin.

Authors:  Peng Yin; Zhuchi Tu; An Yin; Ting Zhao; Sen Yan; Xiangyu Guo; Renbao Chang; Lianhe Zhang; Yan Hong; Xiahe Huang; Junxia Zhou; Yingchun Wang; Shihua Li; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2014-10-24       Impact factor: 6.150

6.  Assessment of Dysregulation of HERC6 and Essential Biological Processes in Response to Laser Therapy of Human Arm Skin.

Authors:  Saeed Safari; Mohammad Rostami-Nejad; Mostafa Rezaei-Tavirani; Vahid Mansouri; Zahra Razzaghi; Majid Rezaei-Tavirani
Journal:  J Lasers Med Sci       Date:  2020-03-15

7.  Lysine 63-linked polyubiquitination is dispensable for Parkin-mediated mitophagy.

Authors:  Kahori Shiba-Fukushima; Tsuyoshi Inoshita; Nobutaka Hattori; Yuzuru Imai
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

8.  Effects of discontinuing a high-fat diet on mitochondrial proteins and 6-hydroxydopamine-induced dopamine depletion in rats.

Authors:  Delin Ma; Jeffrey M Shuler; Kayla D Raider; Robert S Rogers; Joshua L Wheatley; Paige C Geiger; John A Stanford
Journal:  Brain Res       Date:  2015-04-08       Impact factor: 3.252

9.  Parkin Regulates Mitosis and Genomic Stability through Cdc20/Cdh1.

Authors:  Seung Baek Lee; Jung Jin Kim; Hyun-Ja Nam; Bowen Gao; Ping Yin; Bo Qin; Sang-Yeop Yi; Hyoungjun Ham; Debra Evans; Sun-Hyun Kim; Jun Zhang; Min Deng; Tongzheng Liu; Haoxing Zhang; Daniel D Billadeau; Liewei Wang; Emilie Giaime; Jie Shen; Yuan-Ping Pang; Jin Jen; Jan M van Deursen; Zhenkun Lou
Journal:  Mol Cell       Date:  2015-09-17       Impact factor: 17.970

Review 10.  Targeting Pink1-Parkin-mediated mitophagy for treating liver injury.

Authors:  Jessica A Williams; Wen-Xing Ding
Journal:  Pharmacol Res       Date:  2015-10-24       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.